IL320461A - שיטות לאיתור -mtbr csf טאו ושימושים בו - Google Patents
שיטות לאיתור -mtbr csf טאו ושימושים בוInfo
- Publication number
- IL320461A IL320461A IL320461A IL32046125A IL320461A IL 320461 A IL320461 A IL 320461A IL 320461 A IL320461 A IL 320461A IL 32046125 A IL32046125 A IL 32046125A IL 320461 A IL320461 A IL 320461A
- Authority
- IL
- Israel
- Prior art keywords
- mtbr
- tau
- methods
- detect csf
- csf
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4711—Alzheimer's disease; Amyloid plaque core protein
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/62—Detectors specially adapted therefor
- G01N30/72—Mass spectrometers
- G01N30/7233—Mass spectrometers interfaced to liquid or supercritical fluid chromatograph
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6875—Nucleoproteins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6878—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids in epitope analysis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
- G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
- G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
- G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
- G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
- G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
- G01N2333/96433—Serine endopeptidases (3.4.21)
- G01N2333/96441—Serine endopeptidases (3.4.21) with definite EC number
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Food Science & Technology (AREA)
- Organic Chemistry (AREA)
- Neurology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Neurosurgery (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Peptides Or Proteins (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263425242P | 2022-11-14 | 2022-11-14 | |
| PCT/US2023/079668 WO2024107745A1 (en) | 2022-11-14 | 2023-11-14 | Methods to detect csf mtbr-tau and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL320461A true IL320461A (he) | 2025-06-01 |
Family
ID=91085398
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL320461A IL320461A (he) | 2022-11-14 | 2023-11-14 | שיטות לאיתור -mtbr csf טאו ושימושים בו |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP4619416A1 (he) |
| JP (1) | JP2025539261A (he) |
| KR (1) | KR20250109226A (he) |
| CN (1) | CN120500495A (he) |
| AU (1) | AU2023379437A1 (he) |
| CL (1) | CL2025001424A1 (he) |
| CO (1) | CO2025006348A2 (he) |
| CR (1) | CR20250208A (he) |
| IL (1) | IL320461A (he) |
| MX (1) | MX2025005517A (he) |
| PE (1) | PE20251700A1 (he) |
| WO (1) | WO2024107745A1 (he) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014011972A1 (en) * | 2012-07-13 | 2014-01-16 | Bristol-Myers Squibb Company | Tau immunoassay |
| KR102770650B1 (ko) * | 2015-07-06 | 2025-02-19 | 유씨비 바이오파마 에스알엘 | 타우 결합 항체 |
| EP4013772A4 (en) * | 2019-08-13 | 2024-06-05 | Washington University | METHODS FOR DETECTING MTBR-TAU ISOFORMS AND THEIR USE |
-
2023
- 2023-11-14 IL IL320461A patent/IL320461A/he unknown
- 2023-11-14 CR CR20250208A patent/CR20250208A/es unknown
- 2023-11-14 CN CN202380090864.4A patent/CN120500495A/zh active Pending
- 2023-11-14 WO PCT/US2023/079668 patent/WO2024107745A1/en not_active Ceased
- 2023-11-14 AU AU2023379437A patent/AU2023379437A1/en active Pending
- 2023-11-14 KR KR1020257019771A patent/KR20250109226A/ko active Pending
- 2023-11-14 EP EP23892418.7A patent/EP4619416A1/en active Pending
- 2023-11-14 PE PE2025000998A patent/PE20251700A1/es unknown
- 2023-11-14 JP JP2025527700A patent/JP2025539261A/ja active Pending
-
2025
- 2025-05-12 MX MX2025005517A patent/MX2025005517A/es unknown
- 2025-05-13 CL CL2025001424A patent/CL2025001424A1/es unknown
- 2025-05-16 CO CONC2025/0006348A patent/CO2025006348A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN120500495A (zh) | 2025-08-15 |
| WO2024107745A1 (en) | 2024-05-23 |
| AU2023379437A1 (en) | 2025-05-08 |
| CR20250208A (es) | 2025-08-04 |
| CO2025006348A2 (es) | 2025-06-16 |
| MX2025005517A (es) | 2025-06-02 |
| CL2025001424A1 (es) | 2025-09-05 |
| EP4619416A1 (en) | 2025-09-24 |
| PE20251700A1 (es) | 2025-07-02 |
| KR20250109226A (ko) | 2025-07-16 |
| JP2025539261A (ja) | 2025-12-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2581872B (en) | Rack easy to assemble and disassemble | |
| EP3221813A4 (en) | Methods relating to the detection of recurrent and non-specific double strand breaks in the genome | |
| HRP20180307T1 (hr) | Novi mutanti prongf-a i njihova upotreba u proizvodnji beta-ngf-a | |
| WO2013090228A3 (en) | Maesa japonica extracts and methods of use | |
| IL284886A (he) | הרכבה של חלקים של חיישנים ושיטות שימוש | |
| SG11202010393PA (en) | Bioreactor with freeze-thaw capabilities to enhance product recovery and related methods | |
| PT2951286T (pt) | Microrganismos recombinantes que compreedem enzimas dependentes de nadph e métodos de produção dos mesmos | |
| EP3265988A4 (en) | Skimming to and past points of interest in digital content | |
| GB2633285B (en) | Improvements in or relating to methods of sensing | |
| IL320461A (he) | שיטות לאיתור -mtbr csf טאו ושימושים בו | |
| CA3271912A1 (en) | Methods to detect csf mtbr-tau and uses thereof | |
| GB201215114D0 (en) | Improvements in or relating to the processing of noisy analogue signals | |
| GB201122146D0 (en) | Screening methods to identify compounds useful in the prevention and/or treatment of inflammatory conditions | |
| GB2582626B (en) | Improvements in and relating to tyres | |
| GB201911939D0 (en) | Improvements in and relating to contruction | |
| GB202010371D0 (en) | Methods and uses relating to proteins | |
| GB201708096D0 (en) | Improvements in and relating to acoustic panels | |
| GB201908488D0 (en) | Improvements in and relating to the production of vinyl records | |
| GB201904376D0 (en) | Improvements in or relating to a method of separating and amalysing a component | |
| GB202112662D0 (en) | Improvements in or relating to devices and methods | |
| GB202111709D0 (en) | Improvements in or relating to devices and methods | |
| GB201916497D0 (en) | Improvements in or relating to devices and methods | |
| GB202308562D0 (en) | Novel methods and uses | |
| GB2582538B (en) | Improvements in and relating to testing | |
| GB202316080D0 (en) | Improvements in or relating to devices and methods |